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Gonadotropin-releasing hormone (GnRH) acts via a
G-protein coupled receptor on gonadotropes to increase
cytosolic Ca21 and stimulate gonadotropin secretion.
Sustained exposure causes desensitization of these ef-
fects, but the GnRH receptor has no C-terminal tail and
does not undergo rapid (<5 min) desensitization. Never-
theless, pretreatment of aT3–1 cells with GnRH reduced
the spike Ca21 response to GnRH and decreased the
GnRH effect on inositol 1,4,5-trisphosphate (Ins(1,4,5)P3)
by 30–50%. Ca21-free mediumwith or without thapsigar-
gin also decreased GnRH-stimulated Ins(1,4,5)P3 gener-
ation, implying that attenuation of the Ca21 response
underlies the Ins(1,4,5)P3 reduction rather than vice
versa. Intracellular Ca21 pool depletion cannot explain
desensitization of the Ca21 response because pool deple-
tion and repletion were faster (half-times, <1 min) than
the onset of and recovery from desensitization (half-
times 10–20 min and 4–6 h). Moreover, 1-h GnRH pre-
treatment attenuated the spike Ca21 response to GnRH
but not that to ionomycin, and brief GnRH exposure in
Ca21-free medium reduced the response to ionomycin
more effectively in controls than in desensitized cells.
GnRH pretreatment also attenuated the Ca21 response
to PACAP38. This novel form of desensitization does not
reflect uncoupling of GnRH receptors from their imme-
diate effector system but rather a reduced efficiency of
mobilization by Ins(1,4,5)P3 of Ca
21 from an intact intra-
cellular pool.
Studies over recent years have revealed a general scheme for
homologous desensitization of GPCRs1 involving rapid uncou-
pling of receptors from their G-protein, subsequent sequestra-
tion of receptors from the plasma membrane, and internaliza-
tion followed by proteolytic degradation (1). Mechanisms
underlying rapid desensitization have been documented for a
number of GPCRs, which involve rapid agonist-induced recep-
tor phosphorylation and consequent uncoupling from the recep-
tors effector system (2). Such phosphorylation may be mediated
by protein kinases A or C or by specific G-protein coupled
receptor kinases, and in many cases phosphorylation of specific
amino acids within the C-terminal tail plays a crucial role
(1–4). For example, specific residues in the C-terminal tail of
adenylyl cyclase-activating b-adrenergic receptors have been
identified that undergo agonist-induced phosphorylation by
b-adrenergic receptor kinase. This phosphorylation permits as-
sociation with b-arrestin, thereby inhibiting G-protein binding
and adenylyl cyclase activation (1, 2). The C-terminal tail has
also been found to be involved in internalization of a number of
receptors of this superfamily (3, 4).
GnRH is a hypothalamic decapeptide that acts via GPCRs on
gonadotropes to stimulate the exocytotic secretion of luteiniz-
ing hormone and follicle-stimulating hormone. Agonist occu-
pancy of GnRH receptors causes a G-protein-mediated activa-
tion of PLC that hydrolyzes membrane phosphoinositides
yielding diacylglycerol and inositol phosphates, including
Ins(1,4,5)P3, that respectively activate protein kinase C and
mobilize Ca21 from intracellular stores (5–11). GnRH also in-
creases Ca21 entry into gonadotropes, predominantly via volt-
age-operated Ca21 channels, and the increase in cytosolic Ca21
caused by GnRH is primarily responsible for the increase in
exocytotic hormone release (7–10, 12, 13). Sustained exposure
to GnRH reduces GnRH-stimulated gonadotropin secretion
(homologous desensitization), and this underlies the suppres-
sion of the reproductive system, which is exploited in the major
clinical applications of GnRH analogues (14, 15). Sustained
treatment with GnRH also reduces the number of cell surface
GnRH receptors (down-regulation), and this presumably con-
tributes to desensitization but changes in GnRH receptor num-
ber can be uncoupled from those in gonadotrope responsive-
ness, demonstrating the involvement of additional mechanisms
(16–20).
As with adenylyl cyclase coupled receptors, many PLC-cou-
pled receptors clearly undergo rapid desensitization (21, 22),
and evidence exists that similar regulatory mechanisms oper-
ates for receptors coupled to both effector system (21–23). How-
ever, GnRH receptors are unique amongst the currently known
G-protein coupled receptors in that they lack the C-terminal
cytoplasmic tail, which has proven to be so important for de-
sensitization and/or internalization of other GPCRs (5–7), and
recent work on the kinetics of GnRH-stimulated PLC activa-
tion in aT3–1 cells (a gonadotrope-derived cell line) indicates
that the GnRH receptor does not undergo rapid (,10 min)
homologous desensitization (24). We have shown, however,
that pretreatment for 60 min with GnRH causes a pronounced
reduction the GnRH-induced increase in cytosolic Ca21 concen-
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tration ([Ca21]i) in these cells (25). Both the spike phase of the
response (which reflects mobilization of intracellular Ca21) and
sustained phase of the response (which is dependent upon Ca21
entry across the plasma membrane) were attenuated by GnRH
pretreatment (25). Here we have addressed the relationship
between Ins(1,4,5)P3 generation and Ca
21 mobilization in or-
der to define more closely the cellular loci involved in desensi-
tization of the spike response.
EXPERIMENTAL PROCEDURES
Materials and Cell Culture—Peptides were purchased from Penin-
sula Laboratories Europe Ltd. (Merseyside, UK), and culture media,
sera, and plasticware were from Life Technologies, Inc. or Falcon (Bec-
ton Dickinson, Oxford, UK). Ionomycin and thapsigargin were from
Calbiochem (Nottingham, UK), and fura 2/AM was from Molecular
Probes Inc. (Eugene, OR). D-Ins(1,4,5)P3 (K
1 salt) was from University
of Rhode Island Foundation. D-myo-[3H]Ins(1,4,5)P3 (44 Ci/mmol) and
myo-[2-3H]inositol (14–16 Ci/mmol) was from Amersham International.
All other reagents were from standard commercial suppliers. aT3–1
cells were cultured in serum-supplemented Dulbecco’s modified Eagle’s
medium as described (25, 26). For experiments they were harvested by
trypsinization and then incubated for 1–3 days in 12-well culture plates
(2 ml of medium/well), which for Ca21 imaging experiments contained
untreated round glass coverslips.
Dynamic Video Imaging of Cytosolic Ca21—Video imaging of fura
2-loaded aT3–1 cells was performed as described (27, 28). Cells were
washed and pretreated for 60 min at 37 °C in 0.9 ml of PSS (127 mM
NaCl, 1.8 mM CaCl2, 5 mM KCl, 2 mM MgCl2, 0.5 mM NaH2PO4, 5 mM
NaHCO3, 10 mM glucose, 0.1% bovine serum albumin, and 10 mM
HEPES, pH 7.4) containing 0 (control) or 0.1 mM GnRH with fura 2 (100
ml of 20 mM fura 2/AM) added 30 min before the end of this incubation.
They were then washed several times in PSS, and the coverslips were
loaded into a holder that was fitted into a heating chamber at 37 °C.
Image capture was typically performed within 10–25 min of loading in
approximately 500 ml of PSS or in PSS with 100 mM EGTA and no CaCl2
(Ca21-free medium) using MagiCal hardware, Tardis software, and a
Nikon Diaphot microscope. The cells were excited alternately at 340
and 380 nm, and emitted light was collected at 510 nm averaging the
data from 8 or 16 video frames and subtracting background values
before ratioing. The ratio of fluorescence at 340 and 380 nm was calcu-
lated on a pixel-by-pixel basis and used to determine the Ca21 concen-
tration assuming a dissociation constant of 225 nM for fura 2 and Ca21
at 37 °C. Calibration was performed as described (27, 28).
Quantification of Intracellular D-Ins(1,4,5)P3—D-Ins (1,4,5)P3 mass
was determined using a modification of a radioreceptor assay previ-
ously validated for stereospecificity and positional specificity (29, 30).
Briefly, aT3–1 cells were grown to approximately 80% confluence and
then washed and incubated for 30 min in 1 ml of Krebs/HEPES at 37 °C.
The medium was aspirated and replaced with 150 ml of buffer with the
indicated concentration of GnRH. Incubations were performed in trip-
licate and were terminated at 5–300 s by addition of 150 ml of ice-cold
1 M trichloroacetic acid. For zero time points, trichloroacetic acid was
added before the GnRH. The D-Ins(1,4,5)P3 was then extracted as
described (30) using duplicate aliquots for each of the triplicate samples
and standards (0.1 nM to 3 mM). Protein content of the wells was
determined in 0.1 M NaOH digests of control cells using bovine serum
albumin as standard.
Statistical Analysis and Data Presentation—The figures show data
from a single experiment (representative of four experiments) or the
mean 6 S.E. of data pooled from n independent experiments (raw data
or data normalized as described in the figure legends). Data are re-
ported in the text as mean 6 S.E., and statistical analysis was by
Student’s t test, accepting p , 0.05 as statistically significant. EC50
values were estimated by nonlinear regression using Graphpad Prism
(San Diego, CA). For Ca21 measurements, image analysis was used to
quantify the mean ionized Ca21 in all of the cells in each field of view
(which typically contained 10–50 cells) as well as in individual cells.
The figures show the mean (with or without S.E.) of data pooled from
the indicated number of fields of view. Where spike and plateau Ca21
values are reported these were defined arbitrarily as the maximum
response within 10 s of stimulation and the response after 1 min,
respectively.
RESULTS
In the first series of experiments Ca21 imaging was per-
formed with aT3–1 cells pre-treated with 0 or 0.1 mM GnRH for
60 min and then after extensive washing stimulated with
GnRH during image capture. As shown (Fig. 1,main panel) 0.1
mM caused the expected biphasic [Ca21]i increase in control
cells from a basal value of 52 6 9 nM to a spike of 556 6 76 nM
followed by a plateau of 165 6 13 nM (mean 6 S.E., n 5 7). In
cells pre-treated for 60 min with GnRH basal [Ca21]i was
unaffected (52 6 7 nM, n 5 7), but the spike and plateau
responses to GnRH were attenuated (to 127 6 16 and 124 6 12
nM, respectively, p , 0.05). Further studies characterizing the
time course of desensitization of the spike phase indicated a
significant (p , 0.05) reduction after only 10 min of pretreat-
ment with GnRH (from 605 6 80 to 308 6 73 nM) and that the
spike response to GnRH was maximally attenuated following a
20 min pretreatment (Fig. 1, inset).
In control cells, GnRH caused a rapid increase in Ins(1,4,5)P3
from basal values of 24 6 8 to 246 6 72 pmol/mg protein at 20 s
and Ins(1,4,5)P3 levels were then maintained (Fig. 2). Pre-
treatment for 60 min with 0.1 mM GnRH attenuated this effect
of GnRH at all time points (Fig. 2). A similar inhibitory effect
was seen when the concentration-response curve for the GnRH
effect on Ins(1,4,5)P3 was determined (Fig. 3). Stimulation for
5 s with GnRH caused a concentration-dependent increase in
Ins(1,4,5)P3 with a maximum increase from 15 6 4 to 344 6 37
pmol/mg protein (mean 6 S.E., n 5 5) in control cells. GnRH
pretreatment (0.1 mM GnRH for 60 min) attenuated maximal
GnRH-stimulated Ins(1,4,5)P3 accumulation to approximately
65% of control. Although the EC50 for this effect of GnRH was
increased from 85 to 134 nM by GnRH pretreatment, this dif-
ference was not statistically significant (log10 EC50 values 6
S.E. were 27.07 6 0.07 and 26.87 6 0.14, respectively).
Although the effect of GnRH pretreatment on GnRH-stimu-
lated Ins(1,4,5)P3 production may contribute to desensitization
of the Ca21 response, PLCs are Ca21-dependent (31), so it is
equally possible that desensitization of the Ca21 response
underlies the attenuated Ins(1,4,5)P3 response. To address
this, we assessed the effects of manipulations that alter the
FIG. 1. Homologous desensitization of the GnRH effect on
[Ca21]i in aT3–1 cells. Main figure, cells were pre-treated for 60 min
with medium containing 0 (●) or 0.1 mM (E) GnRH (fura 2/AM present
for the last 30 min of pretreatment) and then washed extensively,
mounted on the microscope stage, and stimulated for the indicated
period with 0.1 mM GnRH in Ca21-containing medium. Each curve
shows the mean 6 S.E. of seven separate experiments. Inset, cells
labeled for 30 min with fura 2 were washed, mounted on the microscope
stage, and incubated for the indicated period in medium with 0.1 mM
GnRH (control cells received no GnRH pretreatment) and then washed
extensively, and stimulated with 0.1 mM GnRH in Ca21-containing
medium. The mean 6 S.E. of maximal spike-phase responses in three to
six experiments is shown for each time point, and the dotted lines show
the upper and lower S.E. limits for basal Ca21 pooled for all experi-
ments. *, p , 0.05, **, p , 0.01 by Student’s t test.


























effect of GnRH on [Ca21]i In normal Ca
21-containing medium
GnRH caused the expected rapid and sustained increase in
Ins(1,4,5)P3, from 16 6 4 at 0 s to 325 6 79 pmol/mg protein at
5 s (Fig. 4). This response was not measurably altered by 2 mM
thapsigargin but was decreased in Ca21-free medium and in
Ca21-free medium with thapsigargin (to 38 6 11 and 33 6 9%
of control respectively, at 300 s). The effect of Ca21-free me-
dium was most pronounced at the later time points (1 and 5
min), and only the combined treatment with thapsigargin in
Ca21-free medium reduced the initial response (to 42 6 10% of
control at 5 s).
We next assessed whether depletion of the GnRH-mobiliz-
able Ca21 pool underlies desensitization of the Ca21 response.
We have shown that treatment with GnRH in Ca21-free or
Ca21-containing medium can deplete the hormone-mobilizable
Ca21 pool (33), but the imaging experiments described herein
were not performed until at least 10 min after the GnRH
pretreatment (the time required to wash the cells and prepare
for imaging), and we suspected that pool refilling may well
have occurred. To assess the time required for pool refilling,
aT3–1 cells were stimulated first for 1 min with 0.1 mM GnRH
in Ca21-free medium (in order to deplete the GnRH-mobilizable
pool). They were then washed extensively (.5 min) in Ca21-
free medium and then either stimulated with 0.1 mM GnRH in
Ca21-free medium or exposed briefly (5–60 s) to Ca21-contain-
ing medium before being returned to Ca21-free medium and
stimulated again with 0.1 mM GnRH. In cells incubated
throughout in Ca21-free medium, the second exposure failed to
increase [Ca21]i (Fig. 5, upper trace). However, brief exposure
(5–60 s) to Ca21-containing medium both increased the [Ca21]i
and enabled GnRH to cause a spike of [Ca21]i elevation during
the subsequent (Fig. 5, middle and lower traces), indicating
that pool refilling had occurred. In cells exposed to Ca21-con-
taining medium for 1 min, the response to the second GnRH
challenge was comparable with that seen in the first, and the
half-time for pool refilling was estimated to be 5–20 s. In
parallel studies the influence of such manipulations on GnRH-
stimulated Ins(1,4,5)P3 accumulation was also addressed. As
shown (Fig. 6), GnRH caused a rapid increase in Ins(1,4,5)P3
levels in control cells (pool intact) stimulated in Ca21-free
medium. This response was attenuated in cells that had been
pre-treated for 1 min with 0.1 mM GnRH in Ca21-free medium
in order to deplete the intracellular Ca21 pool (pool emptied)
and was returned to control values by 1 min of exposure to
normal Ca21-containing medium in order to allow pool refilling
after the GnRH pretreatment (pool emptied and refilled).
Although the experiments described above indicated that
rapid refilling of the GnRH-mobilizable Ca21 pool had oc-
curred, recovery from desensitization was much slower (Fig. 7).
Indeed, aT3–1 cells pre-treated for 60 min with 0.1 mM GnRH
did not recover from such desensitization until at least 4 h after
pretreatment. In order to test the possible involvement of pool
depletion more directly, we compared the effects of GnRH and
the Ca21 ionophore ionomycin on [Ca21]i in control cells (Fig. 8,
left panel) and in cells pre-treated for 60 min with 0.1 mM GnRH
(Fig. 8, right panel). In control cells stimulated in Ca21-free
FIG. 5. Depletion and refilling of the GnRH-mobilizable intra-
cellular Ca21 pool in aT3–1 cells. Cells were loaded with fura 2, then
washed, mounted on the microscope stage, and transferred to Ca21-free
medium 1 min before the start of image capture. They were then
stimulated twice with 0.1 mM GnRH in Ca21-free medium as indicated
by the bars. The break in the horizontal axis represents a period during
which the cells were washed extensively in Ca21-free medium to remove
GnRH. Between the two periods of GnRH stimulation, cells were ex-
posed to normal Ca21-containing medium (hatched bars) for approxi-
mately 60 s (lower trace) or 10 s (middle trace) or were maintained in
Ca21-free medium throughout (control, upper trace). Each curve shows
the mean 6 S.E. of three to six separate experiments. The middle and
upper traces are offset by 400 and 800 nM, respectively, and the S.E.
bars are omitted for clarity.
FIG. 2. Time course of Ins(1,4,5)P3 elevation by GnRH in con-
trol and GnRH pre-treated aT3–1 cells. Cells were pre-treated for
60 min in Krebs/HEPES buffer with 0 or 0.1 mM GnRH and then washed
extensively and stimulated for the indicated period with 0.1 mM GnRH
before processing for Ins(1,4,5)P3 measurement. The data shown are
the means 6 S.E. (n 5 3) of data from a single representative
experiment.
FIG. 3. Dose dependence of Ins(1,4,5)P3 elevation by GnRH in
control and GnRH pre-treated aT3–1 cells. Cells were pre-treated
for 60 min in Krebs/HEPES buffer with 0 or 0.1 mM GnRH and then
washed extensively and stimulated for 5 s with the indicated concen-
tration of GnRH before processing for Ins(1,4,5)P3 measurement. The
data are pooled from five separate experiments (each having triplicate
observations for each time point) normalized as a percentage of internal
control responses (the responses of control cells to 1 mM GnRH), which
were 344 6 37 pmol/mg protein.
FIG. 4. Ca21 dependence of Ins(1,4,5)P3 elevation by GnRH in
aT3–1 cells. Cells were washed and preincubated for 10 min in normal
Ca21-containing medium (filled symbols) or in Ca21-free medium (open
symbols) in the absence (circles) or the presence (triangles) of 2 mM
thapsigargin and then stimulated as indicated in the same medium
with 0.1 mM GnRH, before processing for Ins(1,4,5)P3 measurement.
The data are from three separate experiments (each having triplicate
observations for each time point) normalized as a percentage of internal
control responses (values observed at 5 s), which were 325 6 79
pmol/mg protein.


























medium, both GnRH (0.1 mM, upper trace, left hand panel) and
ionomycin (2 mM, lower trace, left hand panel) transiently in-
creased [Ca21]i. Stimulation with 0.1 mM GnRH almost abol-
ished the subsequent response to ionomycin, whereas 1 nM
GnRH caused a submaximal increase in [Ca21]i and reduced
but did not prevent the subsequent response to ionomycin
(middle trace, left panel). These data indicate that the two
stimuli mobilize Ca21 from a shared intracellular pool and that
the ionomycin response can therefore be used as a measure of
the filling state of the GnRH-mobilizable intracellular Ca21
pool (see also Ref. 32). In cells pre-treated for 60 min with 0.1
mM GnRH, ionomycin alone caused an increase in [Ca21]i, com-
parable with that seen in control cells (compare lower traces in
left and right panels), indicating the retention of this intracel-
lular pool. Stimulation with 1 nM GnRH in Ca21-free medium
did not increase [Ca21]i or reduce the subsequent response to
ionomycin. Stimulation with 0.1 mM GnRH caused only a mod-
est increase in [Ca21]i and reduction of the subsequent iono-
mycin response. The data shown in Fig. 8 are from a series of
experiments from which concentration response curves for the
increase in [Ca21]i caused by GnRH and the reduction in iono-
mycin response due to GnRH were constructed (Fig. 9). As
shown, GnRH caused a dose-dependent increase in [Ca21]i in
Ca21-free medium with an EC50 of 6 nM and also attenuated
the ionomycin response to approximately 15% of control, with
an IC50 of 33 pM. In GnRH pre-treated cells, the EC50 for the
increase in Ca21 could not be calculated but is apparently
greater than 1 mM. In these cells GnRH decreased the ionomy-
cin response to approximately 50% of control with an IC50 of 4.2
nM.
Finally, we compared the effects of GnRH pretreatment on
Ca21 response with GnRH and to PACAP38, another peptide
that acts via GPCRs to activate PLC in aT3–1 cells (36, 37). As
expected, pretreatment for 60 min with 0.1 mM GnRH abolished
the spike response to GnRH seen in Ca21-free medium (Fig. 10,
upper panel). PACAP38 (0.1 mM) caused a comparable spike-
type increase in Ca21 to GnRH, and this effect was also greatly
diminished by GnRH pretreatment (Fig. 10, lower panel).
DISCUSSION
Gonadotropin-releasing hormone is released from the hypo-
thalamus in a pulsatile manner and elicits pulsatile gonado-
tropin secretion. This stimulation pattern maintains respon-
siveness to GnRH, whereas continuous stimulation causes
desensitization and attenuates gonadotropin secretion (16, 38).
Recent studies (24) have revealed, however, that GnRH-stim-
ulated [3H]IPtotal accumulation (an indicator of PLC activity
measured in cells labeled with [3H]inositol and stimulated in
the presence of LiCl) remains linear for 10 min after stimula-
tion. These data argue against rapid agonist-induced uncou-
pling of the GnRH receptor from its effector system (G-proteins
activating PLC), possibly because it lacks the C-terminal tail,
which has been implicated in homologous desensitization of
other GPCRs and rhodopsin (39, 40). Desensitization of GnRH-
induced Ca21 responses can, however, be demonstrated within
an intermediate time frame. Pretreatment for 60 min with
GnRH causes a dose-dependent reduction in the ability of
GnRH to increase Ca21 in aT3–1 cells (25) and comparable
effects are seen in primary cultures of rat pituitary cells2 and
with GnRH receptors transfected into HEK-293 cells (34). This
pretreatment caused desensitization of both spike and plateau
phases of the Ca21 response to GnRH in aT3–1 cells and also
decreased the effect of KCl on [Ca21]i (25), supporting the
suggestion that desensitization occurs at the level of voltage
operated Ca21 channels in gonadotropes and aT3–1 cells (25,
41) but leaving the mechanism underlying desensitization of
the spike Ca21 response unresolved.
In addition to attenuation of the effect of GnRH on [Ca21]i,
pretreatment with GnRH has been shown to decrease GnRH-
stimulated [3H]IPtotal accumulation by approximately 25%
(25), but in these experiments total [3H]IPtotal accumulation
was measured in cells labeled with [3H]inositol. This has the
possible disadvantages that PLC activity directed against
phospholipids other than PIP2 may be quantified (21) and that
the GnRH pretreatment may have altered the specific activity
of the [3H]inositol-labeled phospholipid substrate pool. Accord-
ingly, we have now examined the relationship between GnRH
effects on Ins(1,4,5)P3 mass levels and on [Ca
21]i in control and
GnRH pre-treated cells. We show here that pretreatment for 60
min with 0.1 mM GnRH causes desensitization of both spike and
plateau phases of the Ca21 response to GnRH (Fig. 1, see also
Ref. 25) and that desensitization of the spike response is rela-
tively rapid in onset (half-time 10–20 min) but is only slowly
reversed (half-time 4–6 h). Desensitization of the Ca21 re-
sponse was associated with a reduction in the effect of GnRH on
2 C. A. McArdle and W. Forrest-Owen, unpublished observations.
FIG. 7. Recovery from desensitization. Cells were pre-treated for
1 h with 0 (control) or 0.1 mM GnRH and then washed extensively and
maintained without GnRH for the indicated period before being stim-
ulated as indicated (arrow) during imaging with 0.1 mM GnRH. Fura 2
loading was always in the 30 min immediately before imaging. The data
shown are the means 6 S.E. of three separate experiments except for
the control curve, which shows the mean 6 S.E. for 15 experiments
(three at each time point).FIG. 6. Influence of depletion and refilling of the GnRH-mobi-
lizable intracellular Ca21 pool Ins(1,4,5)P3 responses to GnRH in
aT3–1 cells. Cells were pre-treated for 1 min in Ca21-free medium with
0 (pool intact) or 0.1 mM (pool emptied) GnRH and then washed and
maintained in Ca21-free medium for a period of 5 min during which one
group of pool-depleted cells were exposed to Ca21-containing medium
for 1 min before being returned to Ca21-free medium (pool emptied and
refilled). The cells were then stimulated as indicated in Ca21-free me-
dium with 0.1 mM GnRH before processing for Ins(1,4,5)P3 measure-
ment. The data are from three separate experiments normalized as a
percentage of internal control responses (the maximum responses seen
in pool intact cells) of 48.2 6 8.9 pmol/well.


























Ins(1,4,5)P3 levels (to between 50 and 80% of control) without
any measurable change in EC50.
Although pretreatment with GnRH clearly reduced the effect
of GnRH on Ins(1,4,5)P3 levels, this effect alone cannot explain
the desensitization of the Ca21 response because the
Ins(1,4,5)P3 responses to 0.1 mM GnRH in control cells and to 1
mM GnRH in GnRH pre-treated cells were indistinguishable,
yet 1 mM GnRH caused very little increase in [Ca21]i in GnRH
pre-treated cells, whereas the [Ca21]i response to 0.1 mM GnRH
is maximal in control cells (Figs. 3 and 9). An alternative
possibility is that the attenuated [Ca21]i increase in the desen-
sitized cells is the cause of the decrease in Ins(1,4,5)P3 because
in other systems Ca21 mobilization supports agonist stimu-
lated Ins(1,4,5)P3 generation, and depletion of intracellular
Ca21 pools can underlie desensitization of Ins(1,4,5)P3 re-
sponses (42, 43). The demonstration that the GnRH effect on
Ins(1,4,5)P3 levels is attenuated in Ca
21-free medium supports
this interpretation. Interestingly, the immediate (5 s) effect of
GnRH on Ins(1,4,5)P3 was only reduced by thapsigargin in
Ca21-free medium (Fig. 4). Thapsigargin specifically blocks the
ATPase, which sequesters Ca21 into rapidly releasable pools in
many cells (32), and as a consequence of continuous leak of
Ca21 from these pools causes their depletion. Thapsigargin,
thereby prevents mobilization of intracellular Ca21 by many
ligands acting via PLC-linked receptors, including GnRH in
aT3–1 cells (33–35). Inhibition of the immediate effect of GnRH
on Ins(1,4,5)P3 levels by thapsigargin in Ca
21-free medium
implies that the maximal Ins(1,4,5)P3 response requires Ca
21
elevation and the lack of effect of thapsigargin in Ca21-contain-
ing medium or of Ca21 -free medium alone suggests that the
Ca21 requirement can be met either by mobilization or entry.
Similarly, depletion of the hormone mobilizable Ca21 pool by
brief pretreatment with GnRH reduced the immediate effect of
GnRH on Ins(1,4,5)P3 in Ca
21-free medium, and this inhibition
FIG. 8. Effect of GnRH pretreatment on elevation of [Ca21]i by GnRH and ionomycin in Ca
21-free medium. Cells were pre-treated for
60 min with medium containing 0 (control, left panel) or 0.1 mM (GnRH pre-treated, right panel) GnRH and then washed, mounted on the
microscope stage, transferred to Ca21-free medium (vertical arrow), and maintained in Ca21-free medium for the duration of the experiment. The
cells were stimulated with 0, 1 nM, or 0.1 mM GnRH (long bar) and after approximately 2 min with 2 mM ionomycin in medium with the same
concentration of GnRH (short bar). Each curve shows the mean of three to six experiments. To improve clarity, S.E. bars are omitted, and the data
for cells stimulated with 1 nM and 0.1 mM GnRH are offset by 750 and 1500 nM, respectively.
FIG. 9. Dose dependences of the effects of GnRH on elevation
of [Ca21]i and depletion of the ionomycin mobilizable Ca
21 pool
in control and GnRH pre-treated cells in Ca21-free medium.
Cells were pre-treated and stimulated exactly as described in the legend
to Fig. 8 (data from the same series of experiments were used). Peak
heights were calculated without background subtraction for the re-
sponses to GnRH (stimulus 1, upper panel) and to ionomycin (stimulus
2, lower panel) and expressed as a percentage of internal control re-
sponses of cells receiving no pretreatment with GnRH. The log10 molar
EC50 value for the GnRH response (upper panel) in control cells was
28.255 6 0.154, and IC50 values for inhibition of the ionomycin re-
sponse by GnRH (lower panel) were210.486 0.164 and28.3736 0.649
(control and GnRH pre-treated cells, respectively).
FIG. 10. Homologous and heterologous desensitization of
GnRH and PACAP38 effects on [Ca21]i in aT3–1 cells. Cells were
pre-treated for 60 min with medium containing 0 or 0.1 mM GnRH (with
fura 2/AM present during the last 30 min of the pretreatment) and then
washed extensively and mounted on the microscope stage. The cells
were then either stimulated as indicated with 0.1 mM GnRH or
PACAP38 in normal Ca21-containing medium (left panels) or trans-
ferred first to Ca21-free medium (vertical arrows) and then stimulated
with GnRH or PACAP38 in Ca21-free medium (right panels) as indi-
cated. Each curve shows the mean 6 S.E. of data from three to six
separate experiments.


























was reversed by brief exposure to normal medium in order to
replenish the Ca21 pool. Together these observations demon-
strate that Ca21 mobilized from intracellular stores during the
spike phase of the response to GnRH exerts a positive feedback
effect on Ins(1,4,5)P3 production, probably reflecting the Ca
21
dependence of PLC (31). Accordingly, the data suggest that
desensitization of the Ca21 response contributes to the ob-
served reduction in Ins(1,4,5)P3 rather than vice versa. Confir-
mation of the fact that this uncoupling does not occur at the
level of the GnRH receptor is provided by the demonstration
that GnRH pretreatment causes comparable inhibition of
the effects of GnRH and of PACAP on [Ca21]i in these cells
(Fig. 10).
The observations above raise the question of why Ins-
(1,4,5)P3 failed to increase [Ca
21]i in GnRH pre-treated cells,
and we have addressed the possibility that this simply reflects
depletion of the hormone mobilizable Ca21 pool as seen in other
systems (44). In Ca21-free medium GnRH caused only a tran-
sient increase in [Ca21]i presumably because the hormone-
mobilizable Ca21 pool became rapidly depleted. This is verified
by the fact that after extensive washing, a second stimulation
with GnRH does not increase [Ca21]i unless the cells are first
exposed to normal Ca21-containing medium to enable pool
refilling (Fig. 5, see also Ref. 32). Using this protocol, and
assuming the maximal increase in [Ca21]i caused by GnRH to
be directly proportional to the filling state of the GnRH mobi-
lizable Ca21 pool, we estimate that pool refilling occurs with a
half-time of 5–20 s (in Ca21-containing medium without
GnRH), which is in stark contrast to the slow recovery from
desensitization of the spike effect of GnRH on [Ca21]i (half-
time 4–6 h). In all of the Ca21 imaging experiments described
here, cells were removed from the pretreatment solution and
then washed extensively in Ca21-containing medium before
transfer to the microscope stage for imaging. Imaging was
therefore not started until at least 10 min after termination of
the pretreatment, and it is most unlikely that pool depletion
had been maintained for this time. Comparison of the rates of
onset of desensitization and of pool depletion also argue against
a causal relationship, because desensitization of the spike
phase of the Ca21 response to GnRH occurred with a half-time
of 10–20 min (Fig. 1), whereas depletion of the GnRH-mobiliz-
able Ca21 pool was complete within 1 min (Fig. 5).
To more directly test the involvement of Ca21 pool depletion,
we exploited the fact that GnRH and ionomycin mobilize Ca21
from shared intracellular Ca21 pools so that responses to iono-
mycin in Ca21-free medium can be used to measure the filling
state of the hormone-mobilizable pool (33). In control cells
GnRH and ionomycin caused comparable transient increase of
[Ca21]i in Ca
21-free medium, and 0.1 mM GnRH dramatically
diminished the [Ca21]i increase on subsequent treatment with
ionomycin. In cells pre-treated for 60 min with 0.1 mM GnRH,
ionomycin caused comparable increases in [Ca21]i to that seen
in control cells indicating that the intracellular Ca21 pool was
intact at the time of ionomycin addition. In contrast, in GnRH-
desensitized cells, 0.1 mM GnRH caused only a minor increase
in Ca21 and very little reduction of the subsequent response to
ionomycin (Fig. 8), suggesting that in these cells, GnRH is
unable to increase Ca21 because it fails to mobilize this extant
intracellular Ca21 pool. Comparison of concentration response
curves from such experiments support this interpretation (Fig.
9). In control cells the brief exposure to GnRH in Ca21-free
medium reduced the subsequent effect of ionomycin to ,15%,
indicating that the vast majority of the ionomycin mobilizable
pool is accessible to GnRH and did so with an IC50 of 33 pM. In
contrast, in the GnRH-desensitized cells the brief GnRH treat-
ment only reduced the ionomycin response to 50%, with an IC50
of 4200 pM. Comparison of EC50 values for GnRH-stimulated
Ins(1,4,5)P3 accumulation (Fig. 3) and inhibition of the iono-
mycin effect on [Ca21]i provides an indication of the efficiency
with which Ins(1,4,5)P3 mobilizes Ca
21. In control cells GnRH
is at least 2000 times more potent at mobilization of Ca21 than
at elevation of Ins(1,4,5)P3 (EC50 values of 33 pM and 83 nM,
respectively), whereas for the GnRH pre-treated cells the dif-
ference is less than 40-fold (EC50 values of 4.2 and 134 nM,
respectively). Thus desensitization of the [Ca21]i response to
GnRH reflects both a reduction in the proportion of the intra-
cellular ionomycin mobilizable Ca21 pool, which can be re-
leased by GnRH, and a reduction in the efficiency of such
mobilization.
In summary, we have found no evidence for uncoupling of
GnRH receptors from their immediate effector system (PLC
activated by Gq/11) even after a relatively protracted period of
stimulation with GnRH. Instead, GnRH pretreatment appar-
ently impairs the efficiency with which Ins(1,4,5)P3 mobilizes
Ca21 from intracellular stores in aT3–1 cells. Although the
reason for this reduction is unknown, we are currently inves-
tigating the possible involvement of Ins(1,4,5)P3 receptor reg-
ulation and cellular compartmentalization of the effector sys-
tem. We suggest that this effect, together with desensitization
of voltage-operated Ca21 channels, may underlie desensitiza-
tion of GnRH-stimulated gonadotropin secretion and that
aT3–1 cells provide a valuable model system for investigation
of the post-receptor regulation of cellular responsiveness to
PLC activating ligands.
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